Foley & Lardner LLP: Prohibition to Prescription: What Trump’s Marijuana Executive Order Really Means
On December 18, 2025, President Donald Trump issued an Executive Order, Increasing Medical Marijuana and Cannabidiol Research, that directs the Attorney General in the most expeditious manner in accordance with federal law, to complete rulemaking process related to...
Krieg Devault: President Trump’s Executive Order on Cannabis Rescheduling: What does it mean?
December 23, 2025 By: Kendall A. Schnurpel On December 18, 2025, President Donald J. Trump issued an Executive Order (the “Order”) directing the federal government to expedite administrative rescheduling of cannabis1 from Schedule I to Schedule III under the...
ArentFox Schiff: Oops, We Did It Again? Executive Action Revives Federal Marijuana Rescheduling Efforts and Sets Research and CBD Policy Priorities
On December 18, President Trump issued an executive order (EO) directing the Attorney General to complete rulemaking to reschedule “marijuana” from Schedule I to Schedule III under the Controlled Substances Act (CSA) and to expand federal research and policy...
DLA Piper: EO accelerates marijuana rescheduling and signals new federal framework for hemp-derived cannabinoids
EO accelerates marijuana rescheduling and signals new federal framework for hemp-derived cannabinoids Written by: Sharon Mayl Joshua Gardner President Donald Trump has issued an Executive Order (EO), “Increasing Medical Marijuana and Cannabidiol Research,” which...
Debvoise & Plimpton: Federal Cannabis Developments: Executive Order on Marijuana Rescheduling and New Risks for the CBD Industry
23 December 2025 Key Takeaways: On December 18, 2025, President Trump issued an executive order directing his administration to complete the process for reclassifying marijuana under the federal Controlled Substances Act, moving it from Schedule I to Schedule III. The...Top 200 Cannabis Lawyers
We Support